Будущее технологий биофармацевтического производства

Аннотация

Поскольку в биофармацевтической отрасли постоянный масштабный рост производства выходит из моды, необходимо наряду с модернизацией уже устаревших подходов применять и инновационные. В статье сделан обзор состояния технологической базы для проведения «даун-стрим» процесса и рассмотрены потенциально возможные решения.

Список ссылок

1. Gottschalk U. / Biopharm. Intl Suppl.. 2006. V. 19. P. 8–9.
2. Hacker D.L., Jesus M. De, and Wurm F.M. / Biotechnol. Adv. 2009. V. 27. P. 1023–1027.
3. Rathore A.S. and Winkle H. / Nat. Biotechnol. 2009. V. 27. P. 26–34.
4. Berthold W., Proceeds. of BioManufacturing World. --- Shanghai, China, 2010.
5. Wurm F.M. / Nature. 2004. V. 22. P. 1393–1398.
6. Aldridge S. / GEN. 2006. V. 26. № 1.
7. Pharmaceutical cGMPs for the 21st Century: A Risk-Based Approach. / FDA. --- Rockville, MD, August 2002.
8. PAT Guidance for Industry: A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance / FDA. --- Rockville, MD, September 2004.
9. Thiel K.A. / Nat. Biotechnol. 2004. V. 22. P. 1365–1372.
10. Sheridan C. / Nat. Biotechnol. 2010. V. 28. P. 307–310.
11. Walsh G. / Nat. Biotechnol. 2010. V. 28. P. 917–924.
12. Gottschalk U. / BioPharm. Intl. Suppl. 2005. V. 18. № 3. P. 24–28.
13. S. Vedantham V. G. and Hubbard B. / Process Scale. Purification of Antibodies, U. Gottschalk (ed.). --- NY: Wiley, 2009. P. 79–102.
14. Glynn J. et al / Biopharm. Intl. Suppl. 2009. V.22. P.15-19.
15. Glynn J. et al., Development of a MAb harvest protocol. Biochemical Engineering XV: Engineering Biology from Biomolecules to Complex Systems. --- Quebec City, Canada, July 15-19 2007.
16. Thommes J. and Etzel M. / Biotechnol. Prog. 2007. V. 23. P. 42-45.
17. Thommes J. and Gottschalk U / Process Scale Purification of Antibodies, U. Gottschalk (ed.). --- NY: Wiley, 2009. P. 293–308.
18. Shulka A.A. and Kandula J.R / Ibid. P. 53–78.
19. Shpritzer R. et al., 232nd ACS National Meeting. --- San Francisco CA, 2006.
20. Glynn J / Process Scale Purification of Antibodies, U. Gottschalk (ed.). --- NY: Wiley, 2009. P. 309–324.
21. Przybycien T., Narahari S., and Steele L. / Biotechnol. 2004. V. 15. P. 469–478.
22. Kent U. / Meth. Mol. Biol. 1999. V. 115. P. 11–18.
23. Page M. and Thorpe R / The Protein Protocols Handbook, 2nd ed., J.M. Walker (ed.). --- Totowa, NJ: Humana Press, 2002. P. 983–984.
24. Lebing W. et al. / Vox Sanguinis. 2003. V. 84. P. 193–201.
25. Parkkinen J. et al. / Vox Sanguinis. 2006. V. 90. P. 97–104.
26. Klyushnichenko V. / Curr. Opin. Drug. Disc. Dev. 2003. V. 6. P. 848–854.
27. Yang et al. M.X. / Proc. Natl. Acad. Sci. USA. 2003. V. 100. P. 6934–6939.
28. Peters J., Minuth T., and Schröder W. / Protein Expr. Purif. 2005. V. 39. P. 43–53.
29. Curling J. and Gottschalk U. / BioPharm. Intl. 2007. V. 21. P. 70–94
30. Gottschalk U. / Adv. Biochem. Eng. Biotechnol. 2010. V. 115. P. 171-183
31. Walter J.K. et al. / Protein Purification: Principles, High Resolution Methods, and Applications, 3rd ed., J.C. Janson (ed.). --- NY: Wiley, 2011.
32. Gottschalk U. / Biotechnol. Prog. 2008. V. 24. P. 496-503.
33. Zhou J. and Tressel T. / Biotechnol. Prog. 2006. V. 22. P. 341–349.
34. Thommes J. and Kula M.R. / Biotechnol. Prog. 1995. V. 11. P. 357–367.
35. Fraud N. et al., BioPharm. Intl. 2009. V. 23. P. 24–27.
36. Faber R., Yang Y., and Gottschalk U., BioPharm. Intl. 2009. V. 23. P. 11–14.
37. Giovannoni L., Ventani M., and Gottschalk U., BioPharm. Intl. 2009. V. 23. № 3.
38. Curtis S. et al. / Biotechnol. Bioeng. 2003. V. 84. P. 179–186.
39. Norling L. / J. Chromatogr. 2005. V. 1069. P. 79–89.